Using data from the US Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System, RSI investigators collaborated on a study showing increased risks of myopericarditis – an inflammatory condition of the heart muscle – following mRNA COVID19 vaccination, with the highest risks seen in young males following a second vaccine dose. Similar findings have been reported by other investigators working with CDC health scientists. RSI investigators noted that the risk of myopericarditis is appreciably higher in individuals with COVID 19 than the risk associated with vaccination.
More RSI News
RSI chairs panel session at Building the Next Generation of Canadian Infrastructure Conference
RSI chairs and presents on panel sessions for the Toronto conference, “Building the Next Generation of Canadian Infrastructure: Defining a roadmap for optimizing infrastructure planning,…
RSI Chairs Joint FAO/WHO Expert Meeting on Microbiological Risk Assessment (JEMRA)
RSI’s Dr. Emma Hartnett chaired the recent Joint FAO/WHO Expert Meeting on Microbiological Risk Assessment (JEMRA). The focus of the week-long event held March 11…
RSI partners with Engineers Canada to offer Online Workshop on the PIEVC Protocol
RSI and Engineers Canada are partnering to offer an online version of the introductory workshop on the PIEVC Protocol for infrastructure climate risk and vulnerability…
RSI contributes to newly published book on Blood Safety.
Written by experts in the field, Blood Safety: A Guide to Monitoring and Responding to Potential New Threats offers a concise yet comprehensive overview on critical issues in monitoring…